Incap starts cooperation with Valkee, the developer of bright light headset to treat seasonal depression
Incap Corporation Stock Exchange Release
22 November 2011 at 9 a.m.
INCAP STARTS COOPERATION WITH VALKEE, THE DEVELOPER OF BRIGHT LIGHT HEADSET TO TREAT SEASONAL DEPRESSION
Incap Corporation and Valkee Ltd have signed a cooperation agreement on manufacturing components of bright light headset, and the first deliveries took place from Incap’s Kuressaare factory in November 2011.
The bright light headset by Valkee Ltd is a new innovation that has attracted both health care professionals and consumers. Valkee substitutes the mood-elevating effects of the sun, by channeling safe bright light directly to photosensitive regions of the brain through the ear canal. That’s why Valkee increases energy, and can act as a preventative or treatment of mood swings and depression. Valkee has CE Class II(a) medical device certification and is clinically tested. In a clinical trial by University of Oulu, 9 of 10 people with seasonal affective disorder felt total symptom relief in four weeks with a daily 8-12 minute dose. Seasonal affective disorder symptoms include fatigue, increase of appetite and increased need for sleep, poor quality of sleep and difficulty to wake up in the mornings during the dark winter months.
Mr Kimmo Akiander, Director of Incap’s Business unit Well-being, is satisfied with the agreement: “People’s interest in their own and their family’s well-being is growing all the time. Valkee’s brain stimulation headset is a totally new innovation promoting well-being, and it fits well into Incap’s manufacturing program. We are delighted that Valkee has chosen Incap as a partner in the manufacture of these devices. “
Cooperation with Valkee is in line with Incap’s strategy, as the company aims to take advantage of global megatrends such as growth in demand for healthcare technology. Incap’s manufacturing program includes a number of medical devices, and the company has an ISO 13485:2003 quality certification for manufacturing of medical devices.
Valkee Ltd’s CEO Mr Timo Ahopelto comments: “Demand on Valkee’s bright light headset has been growing very strongly and especially internationally. The Valkee users are satisfied. This partnership will help us meet the demand according to our high quality standards.”
Valkee Ltd is a healthcare technology company which was established in 2007 and has developed a portable brain stimulation headset to treat seasonal affective disorder. The company’s expertise is based on long-term scientific research and development in collaboration with the University of Oulu. More information about the company is available at www.valkee.com.
For more information:
Sami Mykkänen, President and CEO, tel. +358 40 559 9047
Kimmo Akiander, Business Unit Director, tel. +358 40 839 7966
Hannele Pöllä, Director of Communications and Investor relations, tel. +358 40 504 8296
NASDAQ OMX Helsinki Ltd.
The company’s home page www.incap.fi
INCAP IN BRIEF
Incap Corporation is an internationally operating contract manufacturer whose comprehensive services cover the entire life-cycle of electromechanical products from design and manufacture to maintenance services. Incap’s customers include leading equipment suppliers in energy efficiency and well-being technologies, for which the company produces competitiveness as a strategic partner. Incap has operations in Finland, Estonia, India and China. The Group’s revenue in 2010 amounted to EUR 59.2 million, and the company currently employs approximately 760 people. Incap’s share is listed on the NASDAQ OMX Helsinki. Additional information: www.incap.fi.